Activest Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Activest Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.75K	Sell	28 -7	-20%	-$1.53K	﹤0.01%	665
2026 Q1	$6.62K	Buy	+35	New	+$6.12K	﹤0.01%	773
2025 Q4	–	Sell	-7	Closed	-$923	–	1230
2025 Q3	$923	Hold	7	–	–	﹤0.01%	882
2025 Q2	$743	Buy	+7	New	+$760	﹤0.01%	807

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Activest Wealth Management's JAZZ Position: Q2 2026 in Review

Activest Wealth Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 20% in Q2 2026, selling an estimated $1.53K and leaving 28 shares worth $6.75K. The position accounts for ﹤0.01% of the portfolio, ranked #665.

Activest Wealth Management first reported a position in JAZZ in Q2 2025 and has held it in 4 quarters since. 69 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Activest Wealth Management held 28 shares of Jazz Pharmaceuticals worth $6.75K as of Q2 2026.
Activest Wealth Management sold 7 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.53K.
Jazz Pharmaceuticals made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #665 holding.
Activest Wealth Management first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
69 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.